PCM
CLPT icon

Parsons Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Parsons Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36M Buy
149,170
+1,984
+1% +$25.1K 0.06% 232
2025
Q4 		$2.01M Buy
147,186
+4,450
+3% +$82.5K 0.11% 168
2025
Q3 		$3.11M Sell
142,736
-750
-0.5% -$8.84K 0.18% 126
2025
Q2 		$1.71M Buy
143,486
+950
+0.7% +$12K 0.11% 177
2025
Q1 		$1.69M Buy
142,536
+963
+0.7% +$15K 0.09% 190
2024
Q4 		$2.18M Buy
141,573
+2,600
+2% +$33.7K 0.12% 153
2024
Q3 		$1.56M Buy
138,973
+33,100
+31% +$317K 0.1% 182
2024
Q2 		$571K Hold
105,873
– – 0.04% 301
2024
Q1 		$720K Sell
105,873
-300
-0.3% -$2.1K 0.05% 273
2023
Q4 		$721K Hold
106,173
– – 0.05% 264
2023
Q3 		$532K Hold
106,173
– – 0.04% 283
2023
Q2 		$769K Buy
106,173
+9,400
+10% +$80K 0.06% 246
2023
Q1 		$817K Sell
96,773
-16,816
-15% -$147K 0.07% 239
2022
Q4 		$962K Buy
113,589
+3,919
+4% +$37.1K 0.08% 206
2022
Q3 		$1.14M Buy
109,670
+22
+0% +$290 0.1% 176
2022
Q2 		$1.43M Hold
109,648
– – 0.13% 158
2022
Q1 		$1.14M Sell
109,648
-674
-0.6% -$6.13K 0.09% 205
2021
Q4 		$1.24M Buy
110,322
+4,260
+4% +$63.8K 0.09% 199
2021
Q3 		$1.88M Buy
106,062
+2,450
+2% +$45.9K 0.15% 142
2021
Q2 		$1.98M Buy
103,612
+3,000
+3% +$58K 0.15% 146
2021
Q1 		$2.13M Sell
100,612
-37,172
-27% -$796K 0.17% 131
2020
Q4 		$2.19M Sell
137,784
-18,800
-12% -$169K 0.19% 115
2020
Q3 		$855K Buy
156,584
+5,000
+3% +$22K 0.08% 193
2020
Q2 		$539K Hold
151,584
– – 0.06% 226
2020
Q1 		$543K Buy
151,584
+124,961
+469% +$614K 0.07% 212
2019
Q4 		$128K Hold
26,623
– – 0.01% 339
2019
Q3 		$135K Buy
+26,623
New +$109K 0.01% 331

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Parsons Capital Management's CLPT Position: Q1 2026 in Review

Parsons Capital Management increased its ClearPoint Neuro (CLPT) stake by 1.3% in Q1 2026, buying an estimated $25.1K and bringing the position to 149,170 shares worth $1.36M. The position accounts for 0.06% of the portfolio, ranked #232.

Parsons Capital Management first reported a position in CLPT in Q3 2019 and has held it in 27 quarters since. The position peaked at $3.11M in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Parsons Capital Management held 149,170 shares of ClearPoint Neuro worth $1.36M as of Q1 2026.
  • Parsons Capital Management bought 1,984 ClearPoint Neuro shares in Q1 2026, an estimated $25.1K.
  • ClearPoint Neuro made up 0.06% of Parsons Capital Management's portfolio in Q1 2026, its #232 holding.
  • Parsons Capital Management first reported a position in ClearPoint Neuro in Q3 2019 and has held it in 27 quarters since.
  • Parsons Capital Management's ClearPoint Neuro position peaked at $3.11M in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Parsons Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.